The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global pediatric interventional cardiology market was valued at US$ 2.28 Billion in 2021.
We expect the global pediatric interventional cardiology market to exhibit a CAGR of 6.80% during 2022-2027.
The rising consumer awareness towards several benefits of pediatric interventional cardiology, such as lower risk of infection, shorter postoperative recovery times, and avoidance of large scars among children, is primarily driving the global pediatric interventional cardiology market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective heart treatment to reduce the risk of coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby limiting the demand for pediatric interventional cardiology technique.
Based on the device type, the global pediatric interventional cardiology market can be segmented into closure devices, transcatheter heart valves, atherectomy devices, catheters, balloons, stents, and others. Currently, closure devices hold the majority of the total market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global pediatric interventional cardiology market include Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation, and W. L. Gore & Associates Inc.
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at